Literature DB >> 33316284

Mast cell-derived IL-13 downregulates IL-12 production by skin dendritic cells to inhibit the TH1 cell response to cutaneous antigen exposure.

Juan Manuel Leyva-Castillo1, Mrinmoy Das2, Emilie Artru2, Juhan Yoon2, Claire Galand2, Raif S Geha3.   

Abstract

BACKGROUND: Atopic dermatitis (AD) is characterized by a skin barrier defect aggravated by mechanical injury inflicted by scratching, a TH2 cell-dominated immune response, and susceptibility to viral skin infections that are normally restrained by a TH1 cell response. The signals leading to a TH2 cell-dominated immune response in AD are not completely understood.
OBJECTIVE: Our aim was to determine the role of IL-13 in initiation of the TH cell response to cutaneously encountered antigens.
METHODS: Wild-type, Il13-/-, Il1rl1-/-, and Il4ra-/- mice, as well as mice with selective deficiency of IL-13 in mast cells (MCs) were studied; in addition, dendritic cells (DCs) purified from the draining lymph nodes of tape-stripped and ovalbumin (OVA)-sensitized skin were examined for their ability to polarize naive OVA-TCR transgenic CD4+ T cells. Cytokine expression was examined by reverse-transcriptase quantitative PCR, intracellular flow cytometry, and ELISA. Contact hypersensitivity to dinitrofluorobenzene was examined.
RESULTS: Tape stripping caused IL-33-driven upregulation of Il13 expression by skin MCs. MC-derived IL-13 acted on DCs from draining lymph nodes of OVA-sensitized skin to selectively suppress their ability to polarize naive OVA-TCR transgenic CD4+ T cells into IFN-γ-secreting cells. MC-derived IL-13 inhibited the TH1 cell response in contact hypersensitivity to dinitrofluorobenzene. IL-13 suppressed IL-12 production by mouse skin-derived DCs in vitro and in vivo. Scratching upregulated IL13 expression in human skin, and IL-13 suppressed the capacity of LPS-stimulated human skin DCs to express IL-12 and promote IFN-γ secretion by CD4+ T cells.
CONCLUSION: Release of IL-13 by cutaneous MCs in response to mechanical skin injury inhibits the TH1 cell response to cutaneous antigen exposure in AD.
Copyright © 2020 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atopic dermatitis; IL-13; T(H)1 cells; dendritic cells

Mesh:

Substances:

Year:  2020        PMID: 33316284      PMCID: PMC8184568          DOI: 10.1016/j.jaci.2020.11.036

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   14.290


  46 in total

1.  Injury to the stratum corneum induces in vivo expression of human thymic stromal lymphopoietin in the epidermis.

Authors:  Irena Angelova-Fischer; Isabel M Fernandez; Marie-Hélène Donnadieu; Silvia Bulfone-Paus; Detlef Zillikens; Tobias W Fischer; Vassili Soumelis
Journal:  J Invest Dermatol       Date:  2010-06-17       Impact factor: 8.551

Review 2.  Interleukin-13: Targeting an underestimated cytokine in atopic dermatitis.

Authors:  Thomas Bieber
Journal:  Allergy       Date:  2019-07-15       Impact factor: 13.146

3.  IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals.

Authors:  Lien H Ho; Tatsukuni Ohno; Keisuke Oboki; Naoki Kajiwara; Hajime Suto; Motoyasu Iikura; Yoshimichi Okayama; Shizuo Akira; Hirohisa Saito; Stephen J Galli; Susumu Nakae
Journal:  J Leukoc Biol       Date:  2007-09-19       Impact factor: 4.962

4.  CCCTC-binding factor controls the homeostatic maintenance and migration of Langerhans cells.

Authors:  Tae-Gyun Kim; Mikyoung Kim; Jong-Joo Lee; Sung Hee Kim; Jeong Hwan Je; Yangsin Lee; Min-Ji Song; Yeeun Choi; Youn Wook Chung; Chae Gyu Park; Jin Won Cho; Min-Geol Lee; Yeon-Su Lee; Hyoung-Pyo Kim
Journal:  J Allergy Clin Immunol       Date:  2015-05-01       Impact factor: 10.793

Review 5.  Dendritic cells and the control of immunity.

Authors:  J Banchereau; R M Steinman
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

6.  Deficient contact hypersensitivity reaction in CD4-/- mice is because of impaired hapten-specific CD8+ T cell functions.

Authors:  Pierre Saint-Mezard; Cyril Chavagnac; Marc Vocanson; Jeanne Kehren; Aurore Rozières; Sophie Bosset; Marius Ionescu; Bertrand Dubois; Dominique Kaiserlian; Jean-Francois Nicolas; Frédéric Bérard
Journal:  J Invest Dermatol       Date:  2005-03       Impact factor: 8.551

7.  IgE-mediated mast cell activation induces Langerhans cell migration in vivo.

Authors:  Dunia M Jawdat; Eric J Albert; Geoffrey Rowden; Ian D Haidl; Jean S Marshall
Journal:  J Immunol       Date:  2004-10-15       Impact factor: 5.422

8.  Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation.

Authors:  Daniela Cihakova; Jobert G Barin; Marina Afanasyeva; Miho Kimura; DeLisa Fairweather; Michael Berg; Monica V Talor; G Christian Baldeviano; Sylvia Frisancho; Kathleen Gabrielson; Djahida Bedja; Noel R Rose
Journal:  Am J Pathol       Date:  2008-04-10       Impact factor: 4.307

9.  Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling.

Authors:  Tao Zheng; Min H Oh; Sun Y Oh; John T Schroeder; Adam B Glick; Zhou Zhu
Journal:  J Invest Dermatol       Date:  2008-10-02       Impact factor: 8.551

10.  Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene.

Authors:  H Bour; E Peyron; M Gaucherand; J L Garrigue; C Desvignes; D Kaiserlian; J P Revillard; J F Nicolas
Journal:  Eur J Immunol       Date:  1995-11       Impact factor: 5.532

View more
  7 in total

Review 1.  Inhalant Mammal-Derived Lipocalin Allergens and the Innate Immunity.

Authors:  Tuomas Virtanen
Journal:  Front Allergy       Date:  2022-01-27

Review 2.  Mast cell tissue heterogeneity and specificity of immune cell recruitment.

Authors:  Peter W West; Silvia Bulfone-Paus
Journal:  Front Immunol       Date:  2022-07-29       Impact factor: 8.786

Review 3.  Roles of Mast Cells in Cutaneous Diseases.

Authors:  Takafumi Numata; Kazutoshi Harada; Susumu Nakae
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

Review 4.  Mast Cells and Dendritic Cells as Cellular Immune Checkpoints in Immunotherapy of Solid Tumors.

Authors:  Katerina Kalkusova; Sindija Smite; Elea Darras; Pavla Taborska; Dmitry Stakheev; Luca Vannucci; Jirina Bartunkova; Daniel Smrz
Journal:  Int J Mol Sci       Date:  2022-09-21       Impact factor: 6.208

Review 5.  Two Sides of the Coin: Mast Cells as a Key Regulator of Allergy and Acute/Chronic Inflammation.

Authors:  Zhongwei Zhang; Yosuke Kurashima
Journal:  Cells       Date:  2021-06-28       Impact factor: 6.600

6.  Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients.

Authors:  Jin-Lan Zhang; Yu-Huan Li; Lu-Lu Wang; Hong-Qi Liu; Shuai-Yao Lu; Yong Liu; Ke Li; Bin Liu; Su-Yun Li; Feng-Min Shao; Kun Wang; Ning Sheng; Rui Li; Jin-Jin Cui; Pei-Chun Sun; Chun-Xia Ma; Bo Zhu; Zhe Wang; Yuan-Hao Wan; Shi-Shan Yu; Yongsheng Che; Chao-Yang Wang; Chen Wang; Qiangqian Zhang; Li-Min Zhao; Xiao-Zhong Peng; Zhenshun Cheng; Jun-Biao Chang; Jian-Dong Jiang
Journal:  Signal Transduct Target Ther       Date:  2021-12-06

7.  Fetal Tissue-Derived Mast Cells (MC) as Experimental Surrogate for In Vivo Connective Tissue MC.

Authors:  Caterina Iuliano; Magdalena Absmaier-Kijak; Tobias Sinnberg; Nils Hoffard; Miriam Hils; Martin Köberle; Florian Wölbing; Ekaterina Shumilina; Nicole Heise; Birgit Fehrenbacher; Martin Schaller; Florian Lang; Susanne Kaesler; Tilo Biedermann
Journal:  Cells       Date:  2022-03-08       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.